Trial · NCT03021902
Registered outcomes35
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 20 of 35
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Physical functioning | Hospital discharge (up to 26 weeks after randomization) | 6-minute walk distance |
| Secondary | Overall strength-upper extremity | Hospital discharge (up to 26 weeks after randomization) | MRC Sum-score (Medical Research Council (MRC) Scale for Muscle Strength). Subscales scored 0-5, where 5 is normal. Total score is the sum of the 6 upper extremity subscales. |
| Secondary | Overall strength-lower extremity | Hospital discharge (up to 26 weeks after randomization) | MRC Sum-score (Medical Research Council (MRC) Scale for Muscle Strength). Subscales scored 0-5, where 5 is normal. Total score is the sum of the 6 lower extremity subscales. |
| Secondary | Quadriceps force-lower extremity strength | Hospital discharge (up to 26 weeks after randomization) | Hand held dynamometry |
| Secondary | Distal strength-hand grip strength | ICU and hospital discharge (up to 26 weeks after randomization) | Hand held dynamometry |
| Secondary | Overall Physical Functional status - Short Physical Performance Battery | ICU and hospital discharge (up to 26 weeks after randomization) | Short Physical Performance Battery |
| Secondary | Overall Physical Functional status - Functional Status Score - ICU | ICU and hospital discharge (up to 26 weeks after randomization) | Functional Status Score - ICU 5 items are performed: rolling, transfer from supine to sit, sitting at the edge of bed, transfer from sit to stand, and walking Each task is evaluated using an eight-point ordinal scale ranging from 0 (unable to perform) to 7 (complete independence) Item scores are summed The total score ranges from 0-35, with higher scores indicating better physical functioning. |
| Secondary | Mortality | ICU and hospital discharge (up to 26 weeks after randomization) | Chart review |
| Secondary | Length of ventilation | ICU and hospital discharge (up to 26 weeks after randomization) | Chart review |
| Secondary | ICU stay | ICU and hospital discharge (up to 26 weeks after randomization) | Chart review |
| Secondary | Hospital stay | ICU and hospital discharge (up to 26 weeks after randomization) | Chart review |
| Secondary | ICU readmission | Hospital discharge (up to 26 weeks after randomization) | Chart review |
| Secondary | Re-intubation | Hospital discharge (up to 26 weeks after randomization) | Chart review |
| Secondary | Hospital-acquired infections | Hospital discharge (up to 26 weeks after randomization) | Chart review |
| Secondary | Discharge location (e.g. home vs. rehab) | Hospital discharge (up to 26 weeks after randomization) | Chart review |
| Secondary | Body composition - Ultrasound | Enrollment, hospital discharge, & ICU discharge (up to 26 weeks after randomization) | Ultrasound of quadriceps |
| Secondary | Body composition - CT - Chest when clinically available | Enrollment, hospital discharge, & ICU discharge (up to 26 weeks after randomization) | Chest CT |
| Secondary | Body composition - CT - Abdominal Scan when clinically available | Enrollment, hospital discharge, & ICU discharge (up to 26 weeks after randomization) | Abdominal CT scan at 3rd lumbar vertebra |
| Secondary | Health-related quality of life - SF-36 | Telephone survey at 6 months | 36-Item Short Form Health Survey (SF-36) All items are scored so that a high score defines a more favorable health state. Each item is scored on a 0 to 100 range so that the lowest and highest possible scores are 0 and 100 Items in the same scale are averaged together to create the 8 scale scores. Items that are left blank (missing data) are not taken into account when calculating the scale scores. Scale scores represent the average for all items in the scale that the respondent answered. |
| Secondary | Health-related quality of life - EQ-5D-5L | Telephone survey at 6 months | EuroQol Group standardized measure of health status (EQ-5D-5L) |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03021902/registered